3D structure of the CD26-ADA complex obtained by cryo-EM and single particle analysis

Biochemical and Biophysical Research Communications

Volumn 313, Issue 2, 2004, Pages 223-229

  Ludwig, Kai ^a   Fan, Hua ^a   Dobers, Jörg ^a   Berger, Markus ^a   Reutter, Werner ^a   Böttcher, Christoph ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

3D reconstruction; Adenosine deaminase; CD26; Cryo TEM; Dipeptidyl peptidase IV; Single particle analysis

Indexed keywords

ADENOSINE DEAMINASE; DIPEPTIDYL PEPTIDASE IV; LEUCINE; LYSINE; THREONINE; VALINE;

ALPHA HELIX; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING SITE; CRYOELECTRON MICROSCOPY; CRYSTAL; DENSITY; ENZYME BINDING; HYDROPHOBICITY; IMAGING; MATHEMATICAL COMPUTING; NONHUMAN; PRIORITY JOURNAL;

EID: 0346366453     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.11.112     Document Type: Article

References (49)

1. Morimoto C., Schlossman S.F. The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 161:1998;55-70.
2. De Meester I., Korom S., Van Damme J., Scharpe S. CD26, let it cut or cut it down. Immunol. Today. 20:1999;367-375.
3. Gorrell M.D., Gysbers V., McCaughan G.W. CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand. J. Immunol. 54:2001;249-264.
4. Drucker D.J. Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes. Expert Opin. Investig. Drugs. 12:2003;87-100.
5. Boonacker E., Van Noorden C.J. The multifunctional or moonlighting protein CD26/DPPIV. Eur. J. Cell. Biol. 82:2003;53-73.
6. Mentlein R. Dipeptidyl-peptidase IV (CD26): role in the inactivation of regulatory peptides. Regul. Pept. 85:1999;9-24.
7. De Meester I., Durinx C., Bal G., Proost P., Struyf S., Goossens F., Augustyns K., Scharpe S. Natural substrates of dipeptidyl peptidase IV. Adv. Exp. Med. Biol. 477:2000;67-87.
8. Augustyns K., Bal G., Thonus G., Belyaev A., Zhang X.M., Bollaert W., Lambeir A.M., Durinx C., Goossens F., Haemers A. Curr. Med. Chem. 6:1999;311-327.
9. Bermpohl F., Loester K., Reutter W., Baum O. Rat dipeptidyl peptidase IV (DPP IV) exhibits endopeptidase activity with specificity for denatured fibrillar collagens. FEBS Lett. 428:1998;152-156.
10. Reutter W., Baum O., Loester K., Fan H., Bork J.P., Bernt K., Hanski C., Tauber R. Functional aspects of the three extracellular domains of dipeptidyl peptidase IV: characterization of glycosylation events, of the collagen-binding site and endopeptidase activity. Fleischer B. Dipeptidyl Peptidase IV (CD26) in Metabolism and the Immune Response. 1995;55-79 R.G. Landes Company, Texas.
11. Cheng H.C., Abdel-Ghany M., Pauli B.U. A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J. Biol. Chem. 278:2003;24600-24607.
12. Chen W.T. DPPIV and seprase in cancer invasion and angiogenesis. Adv. Exp. Med. Biol. 524:2003;197-203.
13. Fleischer B. CD26: a surface protease involved in T-cell activation. Immunol. Today. 15:1994;180-184.
14. Tanaka T., Duke-Cohan J.S., Kameoka J., Yaron A., Lee I., Schlossman S.F., Morimoto C. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc. Natl. Acad. Sci. USA. 91:1994;3082-3086.
15. Fan H., Yan S., Stehling S., Marguet D., Schuppan D., Reutter W. Dipeptidyl peptidase IV/CD26 in T cell activation, cytokine secretion and immunoglobulin production. Adv. Exp. Med. Biol. 524:2003;165-174.
16. von Bonin A., Huhn J., Fleischer B. Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway. Immunol. Rev. 161:1998;43-53.
17. Franco R., Valenzuela A., Lluis C., Blanco J. Immunol. Rev. 161:1998;27-42.
18. Yan S., Marguet D., Dobers J., Reutter W., Fan H. Eur. J. Immunol. 33:2003;1519-1527.
19. Morrison M.E., Vijayasaradhi S., Engelstein D., Albino A.P., Houghton A.N. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J. Exp. Med. 177:1993;1135-1143.
20. Kameoka J., Tanaka T., Nojima Y., Schlossman S.F., Morimoto C. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science. 261:1993;466-469.
21. De Meester I., Vanham G., Kestens L., Vanhoof G., Bosmans E., Gigase P., Scharpe S. Binding of adenosine deaminase to the lymphocyte surface via CD26. Eur. J. Immunol. 24:1994;566-570.
22. Dong R.P., Kameoka J., Hegen M., Tanaka T., Xu Y., Schlossman S.F., Morimoto C. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J. Immunol. 156:1996;1349-1355.
23. Martin M., Huguet J., Centelles J.J., Franco R. Expression of ecto-adenosine deaminase and CD26 in cells triggered by the T-cell receptor (TCR/CD3) complex: Possible role of adenosine deaminase as costimulatory molecule. J. Immunol. 155:1995;4630-4643.
24. Lluis C., Franco R., Cordero O. Ecto-adenosine deaminase may play a relevant role in the development of the immune system. Immunol. Today. 19:1998;533-534.
25. Gines S., Marino M., Mallol J., Canela E.I., Morimoto C., Callebaut C., Hovanessian A., Casado V., Lluis C., Franco R. Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase - CD26 interaction. Biochem. J. 361:2002;203-209.
26. Valenzuela A., Blanco J., Callebaut C., Jacotot E., Lluis C., Hovanessian A.G., Franco R. Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles. J. Immunol. 158:1997;3721-3729.
27. Dong R.P., Tachibana K., Hegen M., Munakata Y., Cho D., Schlossman S.F., Morimoto C. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation. J. Immunol. 159:1997;6070-6076.
28. Abbott C.A., McCaughan G.W., Gorrell M.D. Two highly conserved glutamic acid residues in the predicted β propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. FEBS Lett. 458:1999;278-284.
29. Richard E., Arredondo-Vega F.X., Santisteban I., Kelly S.J., Patel D.D., Hershfield M.S. The binding site of human adenosine deaminase for CD26/dipeptidyl peptidase IV: the Arg142Gln mutation impairs binding to CD26 but does not cause immune deficiency. J. Exp. Med. 192:2000;1223-1236.
30. Richard E., Alam S.M., Arredondo-Vega F.X., Patel D.D., Hershfield M.S. Clustered charged amino acids of human adenosine deaminase comprise a functional epitope for binding the adenosine deaminase complexing protein CD26/dipeptidyl peptidase IV. J. Biol. Chem. 277:2002;19720-19726.
31. Rasmussen H.B., Branner S., Wiberg F.C., Wagtmann N. Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog. Nat. Struct. Biol. 10:2003;19-25.
32. Engel M., Hoffmann T., Wagner L., Wermann M., Heiser U., Kiefersauer R., Huber R., Bode W., Demuth H.U., Brandstetter H. The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism. Proc. Natl. Acad. Sci. USA. 100:2003;5063-5068.
33. Ludwig K., Yan S., Fan H., Reutter W., Böttcher C. The 3D structure of rat DPPIV/CD26 as obtained by cryo-TEM and single particle analysis. Biochem. Biophys. Res. Commun. 304:2003;73-77.
34. Kinoshita T., Nishio N., Nakanishi I., Sato A., Fujii T. Structure of bovine adenosine deaminase complexed with 6-hydroxy-1,6-dihydropurine riboside. Acta Crystallogr. D. 59:2003;299-303.
35. Kinoshita T., Nishio N., Sato A., Murata M. Crystallization and preliminary analysis of bovine adenosine deaminase. Acta Crystallogr. D. 55:1999;2031-2032.
36. Wriggers W., Birmanns S. Using situs for flexible and rigid-body fitting of multiresolution single-molecule data. J. Struct. Biol. 133:2001;193-202.
37. Dobers J., Zimmermann-Kordmann M., Leddermann M., Schewe T., Reutter W., Fan H. Expression, purification, and characterization of human dipeptidyl peptidase IV/CD26 in Sf9 insect cells. Protein Expr. Purif. 25:2002;527-532.
38. Dobers J., Grams S., Reutter W., Fan H. Roles of cysteines in rat dipeptidyl peptidase IV/CD26 in processing and proteolytic activity. Eur. J. Biochem. 267:2000;5093-5100.
39. Ludwig K., Baljinnyam B., Herrmann A., Böttcher C. The 3D structure of the fusion primed Sendai F-protein determined by electron cryomicroscopy. EMBO J. 22:2003;3761-3771.
40. van Heel M. Angular reconstitution: a posteriori assignment of projection directions for 3D reconstruction. Ultramicroscopy. 21:1987;111-123.
41. van Heel M., Harauz G. Biological macromolecules explored by pattern recognition. Scanning Microsc. Suppl. 2:1988;295-301.
42. Daddona P.E., Kelley W.N. Human adenosine deaminase binding protein. Assay, purification, and properties. J. Biol. Chem. 253:1978;4617-4623.
43. Andy R.J., Kornfeld R. The adenosine deaminase binding protein of human skin fibroblasts is located on the cell surface. J. Biol. Chem. 257:1982;7922-7925.
44. Schrader T., Loidl A., McIntyre G.J., Zeyen C.M. Single-crystal neutron-diffraction study of the orientational glass state of (NaCN)1-x(KCN)x. Phys. Rev. B. 42:1990;3711-3718.
45. Kinoshita K., Furui J., Nakamura H. Identification of protein functions from a molecular surface database, eF-site. J. Struct. Funct. Genomics. 2:2002;9-22.
46. Kähne T., Lendeckel U., Wrenger S., Neubert K., Ansorge S., Reinhold D. Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review). Int. J. Mol. Med. 4:1999;3-15.
47. Gorrell M.D., Abbott C.A., Kähne T., Levy M.T., Church W.B., McCaughan G.W. Relating structure to function in the beta-propeller domain of dipeptidyl peptidase IV. Point mutations that influence adenosine deaminase binding antibody binding, and enzyme activity. Adv. Exp. Med. Biol. 477:2000;89-95.
48. Wilson D.K., Rudolph F.B., Quiocho F.A. Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. Science. 252:1991;1278-1284.
49. Abbott C.A., McCaughan G.W., Levy M.T., Church W.B., Gorrell M.D. Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain. Eur. J. Biochem. 266:1999;798-810.